CRSP

Apocalyptic-Post

CRSP 🚀🚀

Apocalyptic-Post

CRSP running again

ThatOneRedditBro

CRSP Crispy....so crispy....

breadkittensayy

God I am so fucking awful this week. Had RIOT 7/3 calls, sold for measly 10% gain (now up 500%). Had CRSP 7/3 50 calls (sold for 20% LOSS) now up 300%. I just am terrified of buying and holding in this stupid fucking market

Apocalyptic-Post

Holding a buttload of CRSP 7/25 calls. Just keeps melting up. Monthly chart looks sexy. I have faith because this sub never mentions it

Str8truth

Your core holding would normally be VTI, which tracks the CRSP total US equity market index. VONG tracks the Russell 1000 (large company) growth-stock index, which goes up faster and comes down faster than the broad index, generally speaking. I'd add something like VONG for spice alongside something like VTI. I would not use VONG alone as my core holding.

Apocalyptic-Post

CRSP

whwji0r

For some reason, CRSP had a lot of activity on far out of the money calls expiring in 2 days. They going to announce they cured cancer?…:s

ThatOneRedditBro

CRSP fomo. 

I_Own_A_Fedora_AMA

Not 50% and the thread is dead but BRK is at its 200 day moving average. PLD is about 50% off and on my buy list. BCC is about half off too and I’ve averaged down a ton to keep its target weight in my actual portfolio. RIO is around 30% off. RIVN is cheap, I won’t pretend it was ever worth IPO price but the earnings are great and the price is low now. CRSP is 75% off of ATH. There you go. I’ve run the gambit. Large cap diversified, industrial real estate, basic materials, EV tech company, biotech. These are just the ones I like and that I’m aware of, I’m sure if I put the effort in there’s probably several dozen Russel components I would call fantastic buys 50% off.

Apocalyptic-Post

CRSP

EvanDDavidson

CRSP is looking promising...surprised call options aren't more expensive.

rueggy

Agree with you on GOOGL. Feels like META back when it was beaten down. Im bagholding CRSP and a couple other CRISPR stocks and praying my patience will someday be rewarded.

ReedB04

CRSP. Gene editing is greater than AI.

fordprecept

EVTL (Vertical Aerospace) - electric flying taxis NIO - high risk/high reward electric car play CRSP (CRSPR) - I've bought and sold this a couple of times. I think it'll take off eventually, but I don't have the patience to wait it out. WGO (Winnebago) looks like a good value play. I think whenever interest rates come back down it will start to rise again SKY (Champion Homes) - another stock I think will rise significantly once interest rates are lowered. UNH (United Health) - Yes, they are evil bastards, but the stock is oversold. BDX (Becton Dickinson) - Another oversold medical stock PCVX (Vaxcyte) - Vaccine maker. If it can outlast the Trump administration (at least until RFK Jr. inevitably gets fired), then I think the stock will recover. INTC (Intel) - new CEO is focused on AI development. Stock is very cheap right now.

xLecavalierx

CRSP An emerging bio tech. AI will enhance the many companies in this space in the coming years. Results will lead to more investment in the space which provides opportunities to the companies with wherewithal. I like CRSP because they had some early success and already inked a deal w Vertex which buys them runway and legitimized the tech. They have a solid pipeline over the next 2 years. LT, they could turn into a Vertex with solid cash flow or they could get scooped up by a PFE type. A buy and forget for me, anything under $50 is just fine.

ThatOneRedditBro

There's volume coming in right now. Could be people anticipating a big jump Monday. Whenever it happened to other companies they generally had a big day. If we hit $50 on Monday (Less than 10%), that could trigger the shorts to cover. My guess is some are exiting now before Monday. Mid year results should come very soon. If I were CRSP management, I would prepare the PR campaign Monday by announcing the Russell entry and share positive results so investors pile in. Combine that with a squeeze and they'll be on CNBC to get more name recognition.

MADD-Scientis

I am curious how much of an impact this will have. I asked a friend that worked at S&P and supposedly there will be several hundred million of $ dumped into CRSP through passive flows that track the index. Unclear if that has started to happen already of it will be at close today/open Monday.

ThatOneRedditBro

CRSP enters Russell 3000 June 27th. You have that catalyst too.

breadkittensayy

CTX310 phase 1 positive news though. Pretty significant reduction in LDL and triglycerides. Also CRSP added to Russel 3000. I dunno we’ll see, could see it popping above 50 here this week. Not really that worried about delay in 320. Think you were right on your initial DD that Lily investing a billion in gene editing is a sign of things to come.

breadkittensayy

CRSP added to the Russell 3000. Super bullish on CRSP and gene editing. I think RFK jr, who was a past investor in CRSP, is going to publicly come out in support of gene editing and this thing will rocket

breadkittensayy

CRSP probably

breadkittensayy

CRSP to 50 tomorrow and 100 by the end of the year. Do you think fatass Trump and his band of cronies are going to walk around without being crisped? Fuck no! They need their genes edited ASAP so they can keep eating McDonald’s for breakfast without their hearts exploding.

ThatOneRedditBro

Get in biotech. CRSP revealed positive results  Tomorrow its added to Russell 3000 Technical squeeze 

moorhound

Blown out on CRSP calls and CRCL puts. I don't know why I bother with any options outside of SPY scalps

moorhound

Guh, I guess CRSP was a sell the news kinda play and I slept in. Hoping for a pop tomorrow to save these calls

moorhound

Hoping CRSP cures cancer by Friday open

Apocalyptic-Post

July CRSP calls

PaperHands_BKbd

>4% of companies drove all of the gains in excess of T bills over the entire history of the market This stat is highly misleading. The study found 4% COULD account for the gains in the market over an almost 100 year span. It detracts any that have closed, merged, or changed in any way. Here's the actual finding, from the author >What I found is that when you compounded the returns for stocks over the full time that they were included in the \[CRSP\] database, that only about 43%, roughly three out of seven of the stocks, turned in better performance than Treasury bills over the same months, the same period of time that the stock was listed and included in the database. So, around the flip side, about 57% or, four out of seven, failed to beat Treasuries.

Ok-Flatworm-3397

I sold some stocks like HOOD, LEU, CRSP and I have only a few regrets :(

Ill_Marzipan_609

also the company CRSP doesnt have sole rights to the CRISPR technology. that is a highly risky play, crazy to see that it was valued at near $200 at one point

Vast-Recognition2321

CRSP.

Professional_Help_85

CRSP... yes i'm a bag holder

ServerTechie

Individual stocks are always higher risk versus ETFs or mutual funds. AAPL is the only individual stock I have anymore, but I’ve owned it for many years. CRSP has some serious potential, but I grew impatient and sold it. If NVDA or MSFT have another big dip, I might buy some, but it’s kinda silly since they already exist in most index funds. Happy to give you some favorite ETFs though. IDMO is a beast for international, and I’m fond of FIVA as well. I have a small position for ICOP. I genuinely believe copper and copper mining are a smart investment in the coming decades. FSELX is volatile but otherwise a great mutual fund for semiconductors. I contribute a little every week to FBTC. I don’t like cryptocurrency, but sadly I think it’s here to stay. I won’t deny it, it’s performed very well.

Awkward_Awareness_37

CRSP’s market value (~$2.9 B) is roughly 2.2× the upfront portion of the Verve acquisition. Given Verve got $1.3 B for early-stage in vivo biotech, CRSP could realistically command a valuation of $6B+ and with 65.7 million shares outstanding each share is worth $91.30

Awkward_Awareness_37

lol sounds like you want me to do your homework for you. CRSP’s market value (~$2.9 B) is roughly 2.2× the upfront portion of the Verve acquisition. Given Verve got $1.3 B for early-stage in vivo biotech, CRSP could realistically command a valuation between $6B+

No-Transportation843

CRSP still behaves like a hype stock so follow the hype. If rfk starts yapping about it, it'll moon 

Grunblau

Sounds like CRSP is fixed to take some of you guys extra chromosomes away….

ThatOneRedditBro

If rate cuts are coming, which will be a tailwind for biotech, mergers and acquisitions will likely come fast to scoop them up for the cheap. A lot of biotech has been hammered last half decade and are bouncing off multi year lows. Verve was just purchased and other biotechs like CRSP are seeing average volume or more over the last month. They are accumulating.

JustLurkCarryOn

Not EDIT specific, but I also believe we will see a rotation into gene editing tickers soon. CRSP, NTLA, EDIT, PRME all good spec buys rn.

IronyElSupremo

Could get one or 2 “best of” stocks from each general sector (tech, oil, banks, consumer staples, etc..), maybe equal or in proportion to an index (if “mega”, I’d say use the S&P100 or Vanguard CRSP megacap fund as a guide). Maybe buy on weakness. Problem I’m seeing is not catching the growth rising stocks coming from “mid-cap” ..

Oplllia

CRSP 🫰🫶🌑🚀

TimelyAd8822

“CRISPR is the **Ctrl+X, Ctrl+V** for your genes. Cut out disease, paste in tendies. Long $CRSP $NTLA $BEAM. Biotech Jesus has entered the chat.” 🧬💥🚀

Heavy_Special_477

Sell TSLA, Hodl APLD, Buy AMC, Someone also said Buy CRSP but idk

Larryisthelobster

$CRSP

Comfortable-Jury6070

CRSP fair value rating at $106/ share

SpiderPiggies

Same here with CRSP. Technically, I'm up since I bought back in at the mid 30's, but I had held it from the 80's to about 50 before moving on briefly. I'm less interested in their cancer stuff, even if it's their best potential money maker in the near term. I'm more interested in their efforts to make a 'cure' for diabetes that doesn't require immune suppression. If they can figure out gene editing that doesn't require immunosupression, the sky is the limit. Ultimately, it's a very small portion of my holdings if it doesn't end up working out.

Comfortable-Jury6070

CRSP fair value listed at $106, holy shit

Comfortable-Jury6070

CRSP saving my portfolio today

John_OSheas_Willy

CRSP. Put 1k into it as my moonshot gamble around 2021. Bought at 122, currently down 70%.

Small-Manner6588

>CRSP lol

Secret_Illustrator88

I've been in CRSP for a long time now. It's killing me, but I still hold hope.

unevenvenue

Not just $CRSP. Also $EDIT, $BEAM, and $NTLA. All of them are working on *in vivo* editing - the moment these companies figure out the protein vehicles for *in vivo*, we'll start watching them work on *in vitro*. Then all bets are off.

Kemilio

CRSP. Gene editing _will_ be a huge player in biotechnology and medicine, it’s just a question of when. This sub is extremely skeptical on bio stocks from what I’ve see though.

michael_curdt

Here are some that no one mentioned yet: CRSP, U, MRVL, ASML, NVO, TMO, MRK, AMAT

StacyWithoutAnE

Both NVCR & CRSP are down tremendously from when I bought in 2021. Hell, NVCR recently dropped just over 10% in one day. DOCU has also been a huge bust since the end of the COVID era, as well, but I'm hopeful they'll be able to bounce back. Or get bought out.

Advanced-Virus-2303

IBIS, NVDA, CSX, CRSP, puts in PLTR

Forsaken_Pop_7951

Thanks. I think the gene-editing space is quite exciting, and part of the challenge we have as investors is to understand how revenue and profit from a one single (or few) therapy(ies) might compare to typical pharma approach to treat disease (or its symptoms) with ongoing drugs. While I like the entire gene-editing space, I have greater focus on NTLA than CRSPR due to (a) CRSPR being a bit ahead of NTLA where they are already commercializing gene-editing therapy thus some of that being already priced-in into their stock price to some extent, (b) NTLA being a bit ahead on in-vivo even while NTLA is still on clinical trail stage which in my opinion this is not priced-in into their stock price yet, (c) NTLA stock is just being hounded by short interest with some pressure to keep price down, and the big shot in my opinion being (d) the potential asymmetry between NTLA and CRSP of upside potential where NTLA could be 5x, 10x, or even =>15x (I hope) while higher risk (and reward) than CRSP, CRSP remains a solid stock in the space who are also pursuing in-vivo but a bit behind than NTLA on that space. While both have tremendous potential, I am betting on NTLA not-yet-priced-in potential for a moonshot price growth (ie. 15x or more if possible, or 10x at least), compared to CRSP 3x or so upside potential for the next 2-5 years. As you alluded, we are merely exchanging opinions, thus hopefully get half of the opinion (or half of the hope) right. I would also add, that I think CRSP is a more solid bet since they are on commercial stage even if still working their way into profit levels, where NTLA is a higher risk since they are just a clinical trial stage company but with a higher reward once they break through approvals and into commercializing territory. In my portfolio I have a few stocks shooting for the moon, NTLA is one of them. Long term, I think both NTLA and CRSP will do very well. I would have money on both, but it just so happens my strategy is focusing on NTLA on the gene editing space just based on shooting for the moon. I have a good size position on NTLA thus taking a huge risk, but the reward could be huge. For those with the stomach and patience, NTLA might be worth the wait. CRSP is a safer bet no matter what, but with a smaller reward in my opinion.

Silent_Road3852

No better feeling than when you transition calls into a regardedly strong stock and it doesnt move when the market tanks. CRSP saved me during post liberation day drops and now RDDT is saving me 

_gpbeast_

Which one is prerevenue? Also I’m in the military so I’ve been trending towards companies winning govt contracts. (Hence Palantir, AMSC, SMCI, Tesla (hoping somehow starlink connects in the future) TMobile because they are using starlink satellites Maybe soundhound? CRSP seemed good at first lol. SMCI brings in billions… I got burned by the audit news last year. And sold all for 1k profit (I was up over 3k and M1 didn’t sell it fast enough, which is why I left). AMSC is increasing revenue.

Prudent-Corgi3793

If you want to exclude a specific company because you hate it for some reason (i.e. political, ethical, etc.), it’s a bit impractical unless you buy 499 stocks individually. You can also buy the index and take a short position but there are trading costs. Since you mentioned Tesla specifically, you can take advantage of the fact that its valuation is ridiculous and that it isn’t profitable in the following manner. A 50/50 split of value and growth funds (VTV and VUG) closely approximates the returns and the factor exposure of VOO for just 4 bp instead of 3 bp. However, Tesla is in VUG despite not growing because the underlying methodology for the CRSP index assigns a stock to one bin or the other. Fortunately, the quality and growth factors are heavily correlated, so you could replace VUG with SPHQ, the S&P quality ETF which would exclude Tesla. tl;dr VTV + SPHQ

papa_autist

Instructions unclear, balls deep in CRSP calls now

whyyunozoidberg

I'm still in OMEX and it's still getting shorted relentlessly, that's the only squeeze one on my radar that still has squeeze potential. I'm also in CRSP which just got really good news. Could squeeze but unlikely.

dropmeonmyownhead

CRSP mostly focuses on ex vivo which is great but harder to scale. PRME is very new but basically search and replace function for genes, as I understand it. One of the many promising technologies to come from David Liu who is basically a greek god of gene editing research. The tech they used for this is actually base editing (also co-created by Liu), which is theoretically a more limited type of editing but right now is the best available.

Spyonetwo

Pardon me but isn’t that what $CRSP does? Are they competition?

Awkward_Awareness_37

CRSP

UPinCarolina

CRSP had some interesting news today. Might be an alright time to go long.

Legaon

—>VTI = tracks the (CRSP US Total Market Index). Large-, mid-, and small-cap equity diversified across growth and value styles. Aka: total US stock market. Determining the index that VTI tracks — is important to know. —>VXUS = tracks the (FTSE Global All Cap ex US Index). Invests in international companies, not US companies. Invests in countries that are classified to be either referred to as (an EMERGING MARKET) or (a DEVELOPED MARKET). AKA: other countries, except the USA. Determining the index that VXUS tracks — is important to know. —>VT = A tracks the (FTSE Global All Cap Index). It is similar to VXUS, but it invests in (international companies + US companies). The safest long term hold, but does not achieve as much capital appreciation compared to VTI ETF. Invests in countries that are classified to be either referred to as (an EMERGING MARKET) or (a DEVELOPED MARKET). —>The USA stock market, is not going to remain as the (best place to invest), forever. Germany underwent hyperinflation during the 1920s + was involved in 2 major wars. Middle Eastern countries, used to be very prosperous in the past — overtime, what has happened. What about India? And other countries. (FTSE Global All Cap Index), is the safest index for an extremely long term hold. It includes (international companies + US companies). Most of the gains, that (VT has achieved over the years), “was because of US companies.”

greytoc

>the S&P 500 is like the 'premium index'? I prefer to characterize it more as a brand with good marketing. Not to take a way from the folks at S&P - but the S&P 500 was not always the baseline index for US large cap equities. >Are there other indexes that do the same thing at a cheaper price? Yes - MSCI (formerly a Morgan Stanley business) has a US Large Cap index product. The index that u/xiongchiamiov mentioned is a Fidelity US Large Cap index but I don't think that Fidelity will license it outside of their own products. FTSE/Russell also has a similar product called the Russell 1000 which is US large cap index. CRSP (center for research in security prices) also has a US large cap index called CRSP US Large Cap Index. I think some Vanguard funds use CRSP indices. >Does S&P own the methodology they use to select the companies, or just the name? An index provider owns the methodology and they decide on the index construction, rebalancing frequency, etc. See here - [https://www.spglobal.com/spdji/en/documents/methodologies/methodology-sp-us-indices.pdf](https://www.spglobal.com/spdji/en/documents/methodologies/methodology-sp-us-indices.pdf) FTSE/Russell methology - [https://www.lseg.com/content/dam/ftse-russell/en\_us/documents/ground-rules/russell-us-indexes-construction-and-methodology.pdf](https://www.lseg.com/content/dam/ftse-russell/en_us/documents/ground-rules/russell-us-indexes-construction-and-methodology.pdf) CRSP Methodology - [https://www.crsp.org/indexes/crsp-market-indexes-methodology/](https://www.crsp.org/indexes/crsp-market-indexes-methodology/)

Ok-Efficiency-5728

Lipid nanotparticle tech FTW! CRSP on the cutting edge of medical tech...again.

Ok-Efficiency-5728

So people finally just reading the news about CRSP this morning??

ConfederacyOfDunces_

What happened to CRSP? Anyone even play that stock anymore?

Ok-Efficiency-5728

CRSP announces positive phase 1 results for LNP delivery system for gene editing in CTX310 and CTX320 results. Net loss at (1.58) per share misses expectations of (1.25) loss.

someonestolemycord

Switch to an alternate index. e.g. S&P to CRSP, MSCI, Bloomberg, etc. To use an example, an index is like Waze. If I am driving, and Waze goes out on my phone, the car does not crash, and I just switch to Google Maps to tell me the route to continue on.

linndrum2

Tell CRSP to go back up. I don't see any news for the 10% drop.

Cajun2Steppa

My ATH are coming. A little rebalance here a little rebalance there. I am not beating the S&P by 10% over the past 2 weeks. MSFT and PM are my big players but CAT NVDA TSM STZ CRSP BEAM making me cock strong

IronyElSupremo

Thematic seems based on a sector, and sector rotation is a tough game to begin with. So “tech” has always been the future, but, with the S&P, it was only the top performing sector twice from 2007 to 2018 (or so). QQQ is tech heavy but also has some “consumer discretionary”. Then for about the same past performance, the “growth” stocks of the indices (S&P, Russell 1000, ..CRSP “mega-cap”) have a lot of tech but ~ half as much in each of these other sectors: communications, consumer discretionary, finance, healthcare, industrials (including military), plus a smattering of utilities and REITs.

ThatOneRedditBro

Shame. I was in the red today on PLTR and CRSP from calls yesterday. Sold at a slight loss after getting some SPY ODTES but would be up huge now if I held. Caught that huge candle on SPY to send me green. Still, tapping out for the day at a $427 gain is a win. All those liberation losses are gone, absolutely wild. This feels like FOMO now back with Virgin Galactic and those other shit companies just ran up like crazy.

RampantPrototyping

CRSP is a decades long play anyways. Human trials involve a lifetime of observation

Kemilio

Good question. I think it’s hard to overstate how big of a player gene editing is going to be in the future of medicine. CRSP is a pioneer in the CRISPR tech, which is a powerful gene editing tool. Yes, it could be years before the potential is realized. It also has a strong research pipeline and a good amount of capital. Finally, it’s my favorite stock to trade. I buy the dips and sell the spikes, maintaining a good base of stock

Puzzleheaded-One-607

What makes you bullish on CRSP? Just curious

Kemilio

Here I am, telling everyone and their dog to buy CRSP for the past few months and then I miss the dip of the year. Ah well, better late than never.

Ok-Efficiency-5728

CRSP has the biggest lead in the space. They have the first approved treatment. Cost aside, Sickle Cell Anemia is no longer a concern because they can fix it. Same for Beta thalassemia. If their next wave of treatments prove to be effective, then the sky is the limit for them.

Outside-Initial955

I’ve maxed out grok (think) for 7 days before getting involved and this is what I’ve got for the inevitable AI/ Biotech future. Am I cooked or nah (long term 5-10yrs) NVDA: 23.7% • PLTR ≈ 14.7% • QQQ=16.4% • SMR: 12.0% • CRSP: 6.5% • RGTI: 5.9% • MSFT: 5.9% • QUBT: 5.6% • RXRX: 5.6% • SOUN: 3.7%

Illustrator_Keys

CRSP US Total Market Index

Yvorontsov

Keeping NTLA, EDIT and CRSP. They will rebound

_AutOfTune_

You're absolutely right $CRSP is flying under the radar despite having real catalysts, strong fundamentals, and now a technical setup that could explode. As for communities: There’s not a forum. I think. Honestly, it feels like we’re still early. Retail hasn’t fully caught on yet — and that could be an opportunity in itself. Let me know if you’re in or just watching happy to share anything I find as this develops.

abiblicalusername

Thanks for posting this. There is not much discussion about this stock but yet plenty of potential, is there a forum where CRSP investor congregate?

Happy_Discussion_536

Rest assured this is normal. The average retard is very bad at stock-picking. SPY is market cap weighted. It is a momentum ETF where winners get to keep running. >“The results also help to explain why active strategies, which tend to be poorly diversified, most often underperform,” says Bessembinder, who found that the largest returns come from very few stocks overall — just 86 stocks have accounted for $16 trillion in wealth creation, half of the stock market total, over the past 90 years. https://wpcarey.asu.edu/department-finance/faculty-research/do-stocks-outperform-treasury-bills Competition, new disruptive threats means companies go bust and lose often. And that's great for society. >I calculate that the approximately 25,300 companies that issued stocks appearing in the CRSP common stock database since 1926 are collectively responsible for lifetime shareholder wealth creation of nearly $35 trillion, measured as of December 2016. However, just five firms (Exxon Mobile, Apple, Microsoft, General Electric, and International Business Machines) account for 10% of the total wealth creation. The 90 top-performing companies, slightly more than one-third of 1% of the companies that have listed common stock, collectively account for over half of the wealth creation. The 1,092 top- performing companies, slightly more than 4% of the total, account for all of the net wealth creation. That is, the remaining 96% of companies whose common stock has appeared in the CRSP data collectively generate lifetime dollar gains that matched gains on one-month Treasury bills. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2900447

lwhitephone81

\>That’s ignoring the availability, study, and analysis of the CRSP data  CRSP is a data set published in 1977 by DFA co-founder David Booth. It's maintained with a $300M "donation" by Booth to the Booth School of Business. \>that academics have used to arrived at similar conclusions. If you're suggesting other academics have validated the CRSP data, that's never happened. In fact, that dataset has never been independently validated, except with recent (1970s-) data by MSCI and others, which shows no SV premium. \>VBR is cheap and has been doing well enough.  The CRSP data says SV should outperform SG by 4% per year. Look at actual fund results and tell me if that in any way reflects reality. \>AVUV ( admittedly ex-DFA folks)  AVUV has provided increased fund cost, taxes, risk, with reduced performance vs total market. It's been great for the sellers, bad for the buyers.

davecrist

I don’t think it’s that clear. That’s ignoring the availability, study, and analysis of the CRSP data that ( evidently — I am not in finance) that academics seem to arrived at similar conclusions. I’d wager that anyone who clearly showed that there was *no* benefit to factor investing would be famous. That said, arguments that ‘crowding’ / popularity of the funds and the rise of private capital keeping ‘quality’ small companies out of the market could impact the benefit could absolutely be right. VBR is cheap and has been doing well enough. 14.25% 5yr CAGR vs 15.14% for VTI for only 7bps. AVUV ( admittedly ex-DFA folks) has done19.72% for 25bps. And VBR is based on the passive sp600 SCV index, far away from the ‘hands on approach’ that avantis/dfa do. So I think there’s something to it. Even if it’s weak or diminished, for me it keeps me doing my consistent weekly DCA when ‘just’ VTI or ‘just market weighting’ wouldn’t. We’ll see in 10 years. 🤷🏽

Strange_Mud_8239

The market cap is 3.3 Billion USD. And ticker is CRSP, not DNA

DaemonTargaryen2024

They track different indices: - VTI: CRSP US Total Market Index - ITOT: S&P Total Market Index

Ok-Efficiency-5728

CRSP. Too much riding on the technology and its implications for humanity at large.

Revfunky

I’m day trading and adding to long term holds. I buy when the VIX hits 40. I’m buying ARM-NET-PSHZF- CRSP-APA.

CthulhuAttack

Go all in shorting the VXX if it opens green on Monday with 4/17 puts anywhere between $50-$60. Either that or put it all in either/both CRSP or KSS long calls. Short squeeze or buyout waiting to happen on both of those. This is just my opinion, not professional investment advice. Always do your own due diligence.

Ok-Efficiency-5728

My boy CRSP showing some regard toughness today

Ok-Efficiency-5728

Any of you bio bros see CRSP? It's almost actually green today.

Psych_Yer_Out

I was up 130k and now down to 105 - 25k unrealized loss It is mostly big tech names and ironically I have a portion of nuclear names too. My nuke stocks are from 5 years ago and have lost a lot of value, but I am still up and will hold longer term 5-10 years. I also hold bio tech mostly CRSP and EDIT, gene editing stocks. I believe in them all as long term holds. So I will hold my cash I raised recently and will short the market as I have been and make money off of the current admin's destruction of the market, for whatever their "reason".

Kemilio

No clue. Tbf, if you haven’t bought already it wouldn’t be a bad idea to DCA into stocks you like. I’ve been picking up small amounts of CRSP and ASTS every dip. The turn around could happen at any time. It’s extremely unlikely to happen soon though.